This article is more than 5 years old. Information may no longer be current.
Carl Zeiss Meditec acquires miLOOP developer IanTECH
Click Here to Manage Email Alerts
Carl Zeiss Meditec will acquire IanTECH, the developer of the miLOOP lens fragmentation device, expanding its cataract surgery portfolio, the company announced in a press release.
“We expect that IanTECH will complement our leading portfolio of equipment and consumables in cataract surgery, allowing us to offer physicians and patients a new standard of care,” Zeiss President and CEO Ludwin Monz, PhD, said in the release. “The technology has the potential to simplify challenging cases, reduce risk to patients and further improve outcomes while being easy to train and adapt for surgeons.”
IanTECH, headquartered in Reno, Nevada, focuses on micro-interventional cataract surgery technology.
“I think there is a shared vision that cataract surgery had seen only incremental innovation with phacoemulsification, which more or less has been the same for the last 50 years,” IanTECH co-founder Sean Ianchulev, MD, MPH, told Healio.com/OSN.
With micro-interventional technology, including the miLOOP, surgeons “can shift the entire paradigm and really create a completely different approach, really optimizing the surgical technique and delivering potentially better outcomes and procedures in the future,” he added.
Disclosure: Ianchulev reports he is the founder and chairman of the board for IanTECH.
Editor’s note: This article was updated to include statements from Sean Ianchulev.
Perspective
Back to Top
John A. Hovanesian, MD, FACS
Founded by physicians for physicians, IanTECH is one of the most innovative and forward-looking companies in eye care. The company has a number of exciting devices in the works, but as I have blogged before, its current flagship product, the miLOOP, belongs in every ophthalmology operating room. Its new partnership with Zeiss will enable this startup to reach more physicians worldwide and propel development of products that will help all of us take better care of patients.
Click Here to Manage Email Alerts